These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 14748557)

  • 1. Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas.
    Kaemmerer D; Sänger J; Arsenic R; D'Haese JG; Neumann J; Schmitt-Graeff A; Wirtz RM; Schulz S; Lupp A
    Oncotarget; 2017 Oct; 8(52):89958-89969. PubMed ID: 29163802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers.
    Kaemmerer D; Specht E; Sänger J; Wirtz RM; Sayeg M; Schulz S; Lupp A
    J Clin Endocrinol Metab; 2015 Mar; 100(3):831-40. PubMed ID: 25494861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin and Somatostatin Receptors in Tumour Biology.
    Kumar U
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy.
    Upton DH; Ung C; George SM; Tsoli M; Kavallaris M; Ziegler DS
    Theranostics; 2022; 12(10):4734-4752. PubMed ID: 35832071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.
    Czajkowski M; Kaemmerer D; Sänger J; Sauter G; Wirtz RM; Schulz S; Lupp A
    BMC Cancer; 2022 Jul; 22(1):740. PubMed ID: 35799158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin Receptor Splicing Variant
    Fuentes-Fayos AC; G-García ME; Pérez-Gómez JM; Peel A; Blanco-Acevedo C; Solivera J; Ibáñez-Costa A; Gahete MD; Castaño JP; Luque RM
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSTR2 is a prognostic factor and a promising therapeutic target in glioma.
    He JH; Wang J; Yang YZ; Chen QX; Liu LL; Sun L; Hu WM; Zeng J
    Am J Transl Res; 2021; 13(10):11223-11234. PubMed ID: 34786053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview.
    Cimini A; Ricci M; Russo F; Egidi M; Calabria F; Bagnato A; Schillaci O; Chiaravalloti A
    Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.
    Günther T; Tulipano G; Dournaud P; Bousquet C; Csaba Z; Kreienkamp HJ; Lupp A; Korbonits M; Castaño JP; Wester HJ; Culler M; Melmed S; Schulz S
    Pharmacol Rev; 2018 Oct; 70(4):763-835. PubMed ID: 30232095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.
    Appay R; Tabouret E; Touat M; Carpentier C; Colin C; Ducray F; Idbaih A; Mokhtari K; Uro-Coste E; Dehais C; Figarella-Branger D;
    Acta Neuropathol Commun; 2018 Sep; 6(1):89. PubMed ID: 30193580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.
    Lange F; Kaemmerer D; Behnke-Mursch J; Brück W; Schulz S; Lupp A
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1227-1237. PubMed ID: 29696364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.
    Kiviniemi A; Gardberg M; Kivinen K; Posti JP; Vuorinen V; Sipilä J; Rahi M; Sankinen M; Minn H
    Oncotarget; 2017 Jul; 8(30):49123-49132. PubMed ID: 28467778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy.
    Kiviniemi A; Gardberg M; Frantzén J; Pesola M; Vuorinen V; Parkkola R; Tolvanen T; Suilamo S; Johansson J; Luoto P; Kemppainen J; Roivainen A; Minn H
    EJNMMI Res; 2015; 5():25. PubMed ID: 25977882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy?
    Lapa C; Linsenmann T; Lückerath K; Samnick S; Herrmann K; Stoffer C; Ernestus RI; Buck AK; Löhr M; Monoranu CM
    PLoS One; 2015; 10(3):e0122269. PubMed ID: 25807228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging biomarkers in primary brain tumours.
    Lopci E; Franzese C; Grimaldi M; Zucali PA; Navarria P; Simonelli M; Bello L; Scorsetti M; Chiti A
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(4):597-612. PubMed ID: 25520293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors.
    Sollini M; Erba PA; Fraternali A; Casali M; Di Paolo ML; Froio A; Frasoldati A; Versari A
    ScientificWorldJournal; 2014; 2014():194123. PubMed ID: 24693229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.
    Kuan CT; Wikstrand CJ; McLendon RE; Zalutsky MR; Kumar U; Bigner DD
    Hybridoma (Larchmt); 2009 Dec; 28(6):389-403. PubMed ID: 20025498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
    Fernandez A; Karavitaki N; Ansorge O; Fazal-Sanderson V; Wass JA
    Pituitary; 2008; 11(3):325-30. PubMed ID: 18000757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of sst1, sst2A, and sst3 somatostatin receptor proteins in low-grade and high-grade astrocytomas.
    Mawrin C; Schulz S; Pauli SU; Treuheit T; Diete S; Dietzmann K; Firsching R; Schulz S; Höllt V
    J Neuropathol Exp Neurol; 2004 Jan; 63(1):13-9. PubMed ID: 14748557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.